Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VRCAVerrica Pharmaceuticals Inc.

Nasdaq · CIK 0001660334
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts314

Identity from submissions API

NameVerrica Pharmaceuticals Inc.
CIK0001660334
TickersVRCA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN463137900
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone484-453-3300
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
44 WEST GAY STREET
SUITE 400
WEST CHESTER
PA
PA
Mailing address
44 WEST GAY STREET
SUITE 400
WEST CHESTER
PA
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

538 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001943462-26-000009 005-90530 261556658 34 74131
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000698 005-90530 261552854 34 10868
2026-11-13 10-Q 10-Q 0001660334-26-000030 001-38529 261549043 34 6760881 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458527 001-38529 261547474 34 294417 1 1
2026-08-18 4 xslF345X06/form4-08182026_050804.xml 0002046750-26-000004 5270
2026-08-18 4 xslF345X06/form4-08182026_050802.xml 0002043558-26-000005 10018
2026-08-18 4 xslF345X06/form4-08182026_050809.xml 0001579649-26-000005 6764
2026-08-18 4 xslF345X06/form4-08182026_050806.xml 0001556327-26-000003 5235
2026-08-06 10-Q 10-Q 0001660334-26-000025 001-38529 261249864 34 40216406 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-338273 001-38529 261249803 34 304329 1 1
2026-06-09 4 xslF345X06/form4-06092026_040606.xml 0001814892-26-000002 5720
2026-06-09 4 xslF345X06/form4-06092026_040603.xml 0001814338-26-000002 5679
2026-06-09 4 xslF345X06/form4-06092026_040601.xml 0001257544-26-000002 5686
2026-06-09 4 xslF345X06/form4-06092026_040614.xml 0001579649-26-000002 6293
2026-06-09 4 xslF345X06/form4-06092026_040612.xml 0002046750-26-000002 6310
2026-06-09 4 xslF345X06/form4-06092026_040610.xml 0002043558-26-000002 6282
2026-06-09 4 xslF345X06/form4-06092026_040608.xml 0001745995-26-000002 5695
2026-06-09 8-K 8-K 5.02,5.07,9.01 0001193125-26-263722 001-38529 261076076 34 325011 1 1
2026-05-12 S-8 S-8 0001193125-26-219912 333-295816 26970040 33 190636 1 1
2026-05-12 10-Q 10-Q 0001660334-26-000014 001-38529 26968721 34 5041866 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001193125-26-219395 001-38529 26968498 34 249215 1 1
2026-04-20 ARS ARS 0001193125-26-164036 001-38529 26875261 34 1425950
2026-04-20 DEFA14A DEFA14A 0001193125-26-164025 001-38529 26875228 34 796389
2026-04-20 DEF 14A DEF 14A 0001193125-26-163961 001-38529 26875134 34 2665319 1 1
2026-03-11 10-K 10-K 0001660334-26-000008 001-38529 26741603 34 10575306 1 1
2026-03-11 8-K 8-K 2.02,9.01 0001193125-26-101126 001-38529 26741595 34 309983 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001229 005-90530 26645057 34 10647
2026-02-02 3/A xslF345X02/form3a-02022026_020243.xml 0002101167-26-000004 5345
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001315863-26-000100 005-90530 26579990 34 14730
2026-01-26 3 xslF345X02/form3-01262026_090154.xml 0002101167-26-000002 7250
2025-12-30 4 xslF345X05/form4-12302025_081201.xml 0001556327-25-000006 4746
2025-12-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000902664-25-005417 005-90530 251611052 34 9363
2025-12-30 3 xslF345X02/ownership.xml 0000902664-25-005416 10941
2025-12-30 3 xslF345X02/ownership.xml 0000902664-25-005415 2990
2025-12-30 8-K 8-K 5.02 0001193125-25-335824 001-38529 251611005 34 142649 1 1
2025-12-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003919 333-292140 251602300 33 1774
2025-12-23 424B3 424B3 0001193125-25-330986 333-292140 251600903 33 164342
2025-12-19 CORRESP filename1.htm 0001193125-25-326765 7022
2025-12-15 S-3 S-3 0001193125-25-319225 333-292140 251571787 33 369119 1 1
2025-12-10 D xslFormDX01/primary_doc.xml 06b 0001231919-25-000594 021-566413 251561991 33 15097
2025-12-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001011438-25-000591 005-90530 251546220 34 15120
2025-11-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001494695-25-000006 005-90530 251536453 34 12092
2025-11-25 4 xslF345X05/form4-11252025_071113.xml 0001579649-25-000004 7464
2025-11-25 4 xslF345X05/form4-11252025_071111.xml 0001556327-25-000004 7727
2025-11-25 4 xslF345X05/form4-11252025_071109.xml 0002046750-25-000004 7768
2025-11-25 4 xslF345X05/form4-11252025_071107.xml 0002043558-25-000003 11213
2025-11-25 4 xslF345X05/form4-11252025_071105.xml 0001494695-25-000004 17359
2025-11-24 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0000902664-25-005145 005-90530 251513183 34 25325
2025-11-24 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-25-292155 001-38529 251509647 34 1105426 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005162 005-90530 251488697 34 10669
2025-11-14 10-Q 10-Q 0001660334-25-000006 001-38529 251487309 34 6517622 1 1
2025-11-14 8-K 8-K 2.02,9.01 0001193125-25-283078 001-38529 251486892 34 295826 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003622 005-90530 251222234 34 10579
2025-08-12 10-Q 10-Q 0000950170-25-107358 001-38529 251207037 34 10713578 1 1
2025-08-12 8-K 8-K 2.02,8.01,9.01 0001193125-25-178954 001-38529 251206802 34 291339 1 1
2025-07-30 8-K 8-K 3.01 0001193125-25-169309 001-38529 251167237 34 142566 1 1
2025-07-23 8-K 8-K 3.03,9.01 0001193125-25-162939 001-38529 251141640 34 155014 1 1
2025-07-01 8-K 8-K 1.01,7.01,9.01 0001193125-25-153471 001-38529 251094199 34 175142 1 1
2025-06-12 8-K 8-K 1.01 0001193125-25-139959 001-38529 251043137 34 137498 1 1
2025-06-09 4 xslF345X05/form4-06092025_040607.xml 0001415889-25-016290 5611
2025-06-09 4 xslF345X05/form4-06092025_040603.xml 0001415889-25-016288 5619
2025-06-09 4 xslF345X05/form4-06092025_040601.xml 0001415889-25-016287 5631
2025-06-09 4 xslF345X05/form4-06092025_040605.xml 0001415889-25-016289 5595
2025-06-05 8-K 8-K 5.07 0001193125-25-135949 001-38529 251027888 34 150616 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072737 005-90530 25954082 34 10801
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002236 005-90530 25951887 34 10578
2025-05-13 S-8 S-8 0001193125-25-118881 333-287233 25940982 33 70913
2025-05-13 10-Q 10-Q 0000950170-25-070452 001-38529 25940799 34 8857448 1 1
2025-05-13 8-K 8-K 2.02,9.01 0001193125-25-118839 001-38529 25940421 34 241347 1 1
2025-04-30 DEFR14A DEFR14A 0001193125-25-105562 001-38529 25890662 34 3185241 1 1
2025-04-25 8-K 8-K 5.02,9.01 0001193125-25-096909 001-38529 25874440 34 183251 1 1
2025-04-22 ARS ARS 0001193125-25-087842 001-38529 25854964 34 802451
2025-04-22 DEFA14A DEFA14A 0001193125-25-087840 001-38529 25854962 34 966532
2025-04-22 DEF 14A DEF 14A 0001193125-25-087838 001-38529 25854957 34 3055110 1 1
2025-04-11 PRE 14A PRE 14A 0001193125-25-079118 001-38529 25832269 34 3069723 1 1
2025-04-02 4 xslF345X05/form4-04022025_080448.xml 0001415889-25-009654 5565
2025-04-02 3 xslF345X02/form3-04022025_080447.xml 0001415889-25-009651 10821
2025-04-02 8-K 8-K 5.02 0001193125-25-071389 001-38529 25805237 34 147949 1 1
2025-03-26 4 xslF345X05/form4-03262025_110341.xml 0001415889-25-008999 5608
2025-03-26 3 xslF345X02/form3-03262025_110359.xml 0001415889-25-008997 9641
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000779 333-285719 25769889 33 1773
2025-03-21 CORRESP filename1.htm 0001193125-25-059980 8045
2025-03-18 4 xslF345X05/form4-03182025_060303.xml 0001415889-25-008506 5620
2025-03-18 4 xslF345X05/form4-03182025_060301.xml 0001415889-25-008505 8074
2025-03-17 UPLOAD filename1.pdf 0000000000-25-002888 333-285719 40106
2025-03-11 S-3 S-3 0001193125-25-052031 333-285719 25728560 33 1839118
2025-03-11 10-K 10-K 0000950170-25-037172 001-38529 25727942 34 12350499 1 1
2025-03-11 8-K 8-K 2.02,9.01 0001193125-25-051957 001-38529 25727781 34 297838 1 1
2025-02-21 8-K 8-K 1.01 0001193125-25-032003 001-38529 25652095 34 144507 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001240 005-90530 25630577 34 10440
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021211 005-90530 25628900 34 11641
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000897 005-90530 25614792 34 16886
2025-02-06 4/A xslF345X05/form4a-02062025_040211.xml 0001415889-25-003234 5580
2025-02-06 4/A xslF345X05/form4a-02062025_040208.xml 0001415889-25-003233 5570
2025-02-06 4/A xslF345X05/form4a-02062025_040206.xml 0001415889-25-003232 5589
2025-02-06 4/A xslF345X05/form4a-02062025_040204.xml 0001415889-25-003231 5564
2025-02-06 4/A xslF345X05/form4a-02062025_040201.xml 0001415889-25-003230 5582
2025-01-30 8-K 8-K 3.01 0001193125-25-017264 001-38529 25573955 34 146986 1 1
2024-12-09 SC 13G/A SC 13G/A 0001193125-24-273581 005-90530 241536570 34 60272
2024-12-09 4 xslF345X05/form4-12092024_101222.xml 0001415889-24-028674 5627
2024-12-09 3 xslF345X02/form3-12092024_101242.xml 0001415889-24-028671 10506
2024-12-09 S-8 S-8 0001193125-24-273484 333-283694 241535779 33 73076
2024-12-09 8-K 8-K 5.02,9.01 0001193125-24-273406 001-38529 241535192 34 203691 1 1
2024-11-26 SC 13D/A SC 13D/A 0001104659-24-123093 005-90530 241503979 34 65596
2024-11-26 4 xslF345X05/form4-11262024_041106.xml 0001415889-24-027711 14420
2024-11-26 4 xslF345X05/form4-11262024_041104.xml 0001415889-24-027710 11201
2024-11-26 4 xslF345X05/form4-11262024_041101.xml 0001415889-24-027709 22437
2024-11-21 8-K 8-K 1.01,8.01,9.01 0001193125-24-263477 001-38529 241485229 34 739263 1 1
2024-11-21 424B5 424B5 0001193125-24-263473 333-268229 241485181 33 651029
2024-11-20 8-K 8-K 8.01,9.01 0001193125-24-262615 001-38529 241481278 34 191105 1 1
2024-11-20 424B5 424B5 0001193125-24-262611 333-268229 241481249 33 653130
2024-11-14 SC 13G/A VERRICA PHARMACEUTICALS INC. 0000902664-24-006523 005-90530 241457811 34 58612
2024-11-06 4 xslF345X05/form4-11072024_021129.xml 0001415889-24-026290 4901
2024-11-06 3 xslF345X02/form3-11072024_021141.xml 0001415889-24-026288 9491
2024-11-06 4 xslF345X05/form4-11072024_021140.xml 0001415889-24-026286 5621
2024-11-06 3 xslF345X02/form3-11072024_011112.xml 0001415889-24-026284 13491
2024-11-06 S-8 S-8 0001193125-24-252195 333-283039 241432172 33 97668
2024-11-05 10-Q 10-Q 0000950170-24-120982 001-38529 241425035 34 7273717 1 1
2024-11-04 8-K 8-K 2.02,5.02,9.01 0001193125-24-250638 001-38529 241423814 34 782236 1 1
2024-10-11 4 xslF345X05/form4-10112024_041004.xml 0001415889-24-025026 5552
2024-10-08 8-K 8-K 3.01,5.02 0001193125-24-234391 001-38529 241360496 34 146382 1 1
2024-10-01 8-K 8-K 2.05 0001193125-24-230240 001-38529 241343888 34 144473 1 1
2024-09-27 8-K 8-K 5.02 0001193125-24-227975 001-38529 241335071 34 142678 1 1
2024-09-23 4 xslF345X05/form4-09232024_040901.xml 0001415889-24-023835 13778
2024-09-06 8-K 8-K 5.02 0001193125-24-215180 001-38529 241284724 34 144830 1 1
2024-08-28 4 xslF345X05/form4-08282024_040809.xml 0001415889-24-022427 7460
2024-08-28 4 xslF345X05/form4-08282024_040807.xml 0001415889-24-022426 7449
2024-08-28 4 xslF345X05/form4-08282024_040805.xml 0001415889-24-022425 7451
2024-08-28 4 xslF345X05/form4-08282024_040804.xml 0001415889-24-022424 7439
2024-08-28 4 xslF345X05/form4-08282024_040801.xml 0001415889-24-022423 7435
2024-08-27 8-K 8-K 5.02 0001193125-24-207814 001-38529 241249808 34 145306 1 1
2024-08-26 144 xsl144X01/primary_doc.xml 0001974078-24-000312 001-38529 241242016 33 5574
2024-08-26 144 xsl144X01/primary_doc.xml 0001974078-24-000311 001-38529 241241912 33 5554
2024-08-26 144 xsl144X01/primary_doc.xml 0001974078-24-000310 001-38529 241240815 33 5537
2024-08-26 144 xsl144X01/primary_doc.xml 0001974078-24-000309 001-38529 241240639 33 5586
2024-08-26 144 xsl144X01/primary_doc.xml 0001974078-24-000308 001-38529 241240584 33 4389
2024-08-14 10-Q 10-Q 0000950170-24-096669 001-38529 241204275 34 7260507 1 1
2024-08-14 8-K 8-K 2.02,7.01,9.01 0001193125-24-200247 001-38529 241204220 34 7397631 1 1
2024-08-05 8-K 8-K 1.01 0001193125-24-193923 001-38529 241174979 34 144216 1 1
2024-07-23 4 xslF345X05/form4-07232024_100700.xml 0001415889-24-019976 7209
2024-07-23 4 xslF345X05/form4-07232024_100716.xml 0001415889-24-019974 7227
2024-07-23 4 xslF345X05/form4-07232024_100729.xml 0001415889-24-019972 7225
2024-07-23 4 xslF345X05/form4-07232024_100729.xml 0001415889-24-019970 7233
2024-07-22 144 xsl144X01/primary_doc.xml 0001974078-24-000250 001-38529 241131479 33 4380
2024-07-22 144 xsl144X01/primary_doc.xml 0001974078-24-000249 001-38529 241131458 33 4391
2024-07-22 144 xsl144X01/primary_doc.xml 0001974078-24-000248 001-38529 241131445 33 4410
2024-07-22 144 xsl144X01/primary_doc.xml 0001974078-24-000247 001-38529 241131432 33 4402
2024-06-28 8-K 8-K 1.01 0001193125-24-172277 001-38529 241085984 34 145237 1 1
2024-06-10 8-K 8-K 5.07 0001193125-24-158353 001-38529 241032976 34 158121 1 1
2024-06-07 4 xslF345X05/form4-06072024_040613.xml 0001415889-24-015961 5601
2024-06-07 4 xslF345X05/form4-06072024_040609.xml 0001415889-24-015959 5637
2024-06-07 4 xslF345X05/form4-06072024_040611.xml 0001415889-24-015960 5625
2024-06-07 4 xslF345X05/form4-06072024_040607.xml 0001415889-24-015958 5631
2024-05-15 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-24-138898 001-38529 24947192 34 192148 1 1
2024-05-13 S-8 S-8 0001193125-24-137265 333-279373 24939615 33 72737
2024-05-13 10-Q 10-Q 0000950170-24-058208 001-38529 24936948 34 6008612 1 1
2024-05-13 8-K 8-K 2.02,9.01 0001193125-24-136715 001-38529 24936909 34 245474 1 1
2024-04-19 ARS ARS 0001193125-24-101659 001-38529 24855630 34 775738
2024-04-19 DEFA14A DEFA14A 0001193125-24-101652 001-38529 24855624 34 993322
2024-04-19 DEF 14A DEF 14A 0001193125-24-101650 001-38529 24855616 34 1188762
2024-03-19 4 xslF345X05/form4-03192024_040300.xml 0001415889-24-008543 7475
2024-03-19 4 xslF345X05/form4-03192024_040351.xml 0001415889-24-008542 7467
2024-03-19 4 xslF345X05/form4-03192024_040349.xml 0001415889-24-008541 7455
2024-03-19 4 xslF345X05/form4-03192024_040347.xml 0001415889-24-008539 7468
2024-03-19 4 xslF345X05/form4-03192024_040342.xml 0001415889-24-008538 7454
2024-02-29 10-K 10-K 0000950170-24-022659 001-38529 24698975 34 9454903 1 1
2024-02-29 8-K 8-K 2.02,9.01 0001193125-24-051876 001-38529 24698910 34 260662 1 1
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036433 005-90530 24639678 34 64500
2024-02-14 SC 13G VERRICA PHARMACEUTICALS INC. 0000902664-24-001598 005-90530 24632931 34 65105
2024-01-08 8-K 8-K 7.01,9.01 0001193125-24-003926 001-38529 24518403 34 18257380 1 1
2023-12-29 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-023292 13160
2023-12-26 4 FORM 4 SUBMISSION 0000899243-23-020691 13639
2023-12-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022861 13164
2023-11-16 4 FORM 4 SUBMISSION 0001209191-23-055542 7181
2023-11-16 4 FORM 4 SUBMISSION 0001209191-23-055534 7177
2023-11-16 4 FORM 4 SUBMISSION 0001209191-23-055531 7167
2023-11-16 4 FORM 4 SUBMISSION 0001209191-23-055528 7165
2023-11-16 4 FORM 4 SUBMISSION 0001209191-23-055527 7189
2023-11-16 144/A xsl144X01/primary_doc.xml 0001974078-23-000206 001-38529 231412855 33 4393
2023-11-15 144 xsl144X01/primary_doc.xml 0001974078-23-000204 001-38529 231411272 33 4370
2023-11-15 144 xsl144X01/primary_doc.xml 0001974078-23-000203 001-38529 231411147 33 4399
2023-11-15 144 xsl144X01/primary_doc.xml 0001974078-23-000200 001-38529 231410870 33 4380
2023-11-15 144 xsl144X01/primary_doc.xml 0001974078-23-000199 001-38529 231410784 33 4354
2023-11-15 144 xsl144X01/primary_doc.xml 0001974078-23-000198 001-38529 231410622 33 4378
2023-11-09 10-Q 10-Q 0000950170-23-061543 001-38529 231390117 34 10582477 1 1
2023-11-09 8-K 8-K 2.02,9.01 0001193125-23-274069 001-38529 231390098 34 292643 1 1
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047524 4895
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047523 4891
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047521 4915
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047519 4906
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047518 4908
2023-08-08 10-Q 10-Q 0000950170-23-039375 001-38529 231149388 34 6830592 1 1
2023-08-08 8-K 8-K 2.02,9.01 0001193125-23-205590 001-38529 231149371 34 262535 1 1
2023-07-27 8-K 8-K 7.01,9.01 0001193125-23-196112 001-38529 231118593 34 6667774 1 1
2023-07-27 144 xsl144X01/primary_doc.xml 0001974078-23-000097 001-38529 231116866 33 4297
2023-07-27 144 xsl144X01/primary_doc.xml 0001974078-23-000096 001-38529 231116845 33 4341
2023-07-27 144 xsl144X01/primary_doc.xml 0001974078-23-000095 001-38529 231116816 33 4313
2023-07-27 144 xsl144X01/primary_doc.xml 0001974078-23-000094 001-38529 231116773 33 4294
2023-07-26 8-K 8-K 1.01,2.03,3.02,7.01,9.01 0001193125-23-194625 001-38529 231113890 34 191710 1 1
2023-07-25 4 FORM 4 SUBMISSION 0001209191-23-043306 7392
2023-07-25 4 FORM 4 SUBMISSION 0001209191-23-043304 7374
2023-07-25 4 FORM 4 SUBMISSION 0001209191-23-043301 7385
2023-07-25 4 FORM 4 SUBMISSION 0001209191-23-043297 7369
2023-07-24 4 FORM 4 SUBMISSION 0001209191-23-043255 8136
2023-07-24 8-K 8-K 7.01,8.01,9.01 0001193125-23-191859 001-38529 231103756 34 3063850 1 1
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036151 5557
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036149 5563
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036147 5551
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036145 5527
2023-06-08 8-K 8-K 5.07 0001193125-23-163516 001-38529 231002114 34 154413 1 1
2023-05-09 10-Q 10-Q 0000950170-23-019169 001-38529 23900110 34 6163006 1 1
2023-05-09 S-8 S-8 0001193125-23-138960 333-271747 23900103 33 70771
2023-05-09 8-K 8-K 2.02,9.01 0001193125-23-138946 001-38529 23900085 34 228447 1 1
2023-04-21 DEFA14A DEFA14A 0001193125-23-109458 001-38529 23834739 34 652855
2023-04-21 DEF 14A DEF 14A 0001193125-23-109424 001-38529 23834699 34 955502
2023-04-21 ARS ARS 0001193125-23-109412 001-38529 23834684 34 1122028
2023-03-06 10-K 10-K 0000950170-23-006118 001-38529 23707608 34 10439829 1 1
2023-03-06 8-K 8-K 2.02,9.01 0001193125-23-060702 001-38529 23707583 34 247778 1 1
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015511 5574
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015507 5588
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015503 5576
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015497 5587
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-015492 5598
2023-02-22 424B5 424B5 0001193125-23-044839 333-268229 23653364 33 597413
2023-02-21 4/A FORM 4/A SUBMISSION 0001209191-23-011127 4903
2023-02-21 8-K 8-K 1.01,8.01,9.01 0001193125-23-043040 001-38529 23645461 34 540434 1 1
2023-02-21 FWP FWP 0001193125-23-042777 333-268229 23645157 34 28899
2023-02-21 8-K 8-K 2.02,8.01 0001193125-23-042756 001-38529 23645119 34 155705 1 1
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038756 005-90530 23627315 34 64811
2023-02-02 8-K 8-K 7.01,9.01 0001193125-23-022755 001-38529 23581127 34 20548031 1 1
2023-01-24 8-K 8-K 8.01 0001193125-23-013704 001-38529 23545881 34 146617 1 1
2022-12-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-12-19 09:00:00 9999999995-22-003580 333-268229 221472770 33 1732
2022-12-19 424B5 424B5 0001193125-22-308333 333-268229 221471267 33 191733
2022-12-15 CORRESP filename1.htm 0001193125-22-305993 77292
2022-11-29 UPLOAD filename1.pdf 0000000000-22-012873 39640
2022-11-18 CORRESP filename1.htm 0001193125-22-288375 28422
2022-11-15 UPLOAD filename1.pdf 0000000000-22-012371 40209
2022-11-08 UPLOAD filename1.pdf 0000000000-22-012149 44709
2022-11-07 S-3 S-3 0001193125-22-279251 333-268229 221366528 33 1359859
2022-11-07 10-Q 10-Q 0000950170-22-022647 001-38529 221365880 34 8006483 1 1
2022-11-07 8-K 8-K 2.02,9.01 0001193125-22-279108 001-38529 221365733 34 264397 1 1
2022-09-14 8-K 8-K 7.01,9.01 0001193125-22-244283 001-38529 221242106 34 24811248 1 1
2022-08-11 10-Q 10-Q 0000950170-22-016660 001-38529 221153770 34 7984470 1 1
2022-08-11 8-K 8-K 2.02,9.01 0001193125-22-218004 001-38529 221153732 34 257137 1 1
2022-07-15 SC 13D SC 13D 0001104659-22-080215 005-90530 221086464 34 82917
2022-07-13 8-K 8-K 8.01 0001193125-22-192901 001-38529 221081242 34 148222 1 1
2022-07-11 4 FORM 4 SUBMISSION 0001209191-22-041835 4611
2022-07-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-015932 8555
2022-07-05 4 FORM 4 SUBMISSION 0001209191-22-040616 4610
2022-07-05 4 FORM 4 SUBMISSION 0001209191-22-040608 4588
2022-07-05 4 FORM 4 SUBMISSION 0001209191-22-040600 4604
2022-07-05 4 FORM 4 SUBMISSION 0001209191-22-040591 4625
2022-07-05 4 FORM 4 SUBMISSION 0001209191-22-040581 6570
2022-07-01 8-K 8-K 1.01,8.01,9.01 0001193125-22-186748 001-38529 221059694 34 415864 1 1
2022-07-01 424B5 424B5 0001193125-22-186744 333-237171 221059687 33 520464
2022-06-29 424B5 424B5 0001193125-22-185052 333-237171 221054759 33 523994
2022-06-14 8-K 8-K 5.07 0001193125-22-173863 001-38529 221015252 34 154808 1 1
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036300 5525
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036298 5495
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036297 5531
2022-06-13 4 FORM 4 SUBMISSION 0001209191-22-036293 5519
2022-06-03 8-K 8-K 2.05 0001193125-22-167332 001-38529 22994605 34 147641 1 1
2022-05-25 8-K 8-K 8.01 0001193125-22-159075 001-38529 22958881 34 147501 1 1
2022-05-09 S-8 S-8 0001193125-22-144468 333-264784 22903513 33 70776
2022-05-09 10-Q 10-Q 0000950170-22-008242 001-38529 22903278 34 7187793 1 1
2022-05-09 8-K 8-K 2.02,9.01 0001193125-22-144294 001-38529 22903262 34 228725 1 1
2022-04-22 DEFA14A DEFA14A 0001193125-22-115138 001-38529 22845603 34 539791
2022-04-22 DEF 14A DEF 14A 0001193125-22-115092 001-38529 22845498 34 475324
2022-04-07 8-K 8-K 7.01,9.01 0001193125-22-098900 001-38529 22814078 34 24324032 1 1
2022-03-02 10-K 10-K 0000950170-22-002685 001-38529 22704630 34 11934285 1 1
2022-03-02 8-K 8-K 2.02,9.01 0001193125-22-063013 001-38529 22703878 34 241947 1 1
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013202 5599
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013199 5591
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013196 5580
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013193 5592
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013191 5578
2022-02-14 5 FORM 5 SUBMISSION 0001209191-22-009596 6773
2022-02-14 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-22-001917 005-90530 22633275 34 79345
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041545 005-90530 22630923 34 67702
2022-02-11 SC 13G/A AMENDMENT NO. 1 0000947871-22-000217 005-90530 22622286 34 66127
2022-01-27 SC 13G/A SC 13G/A 0001193125-22-019277 005-90530 22561406 34 45569
2021-12-15 8-K FORM 8-K 8.01 0001193125-21-357955 001-38529 211494476 34 147496 1 1
2021-12-06 4 FORM 4 SUBMISSION 0001209191-21-068031 10195
2021-11-29 8-K 8-K 7.01,8.01,9.01 0001193125-21-342387 001-38529 211457181 34 24789303 1 1
2021-11-12 10-Q 10-Q 0000950170-21-004249 001-38529 211399664 34 8431341 1 1
2021-11-12 8-K 8-K 2.02,9.01 0001193125-21-327358 001-38529 211399623 34 253271 1 1
2021-09-29 8-K 8-K 7.01,9.01 0001193125-21-286746 001-38529 211291697 34 24782361 1 1
2021-09-20 8-K 8-K 8.01 0001193125-21-277323 001-38529 211263552 34 148069 1 1
2021-08-10 10-Q 10-Q 0001564590-21-042894 001-38529 211158479 34 7465536 1 1
2021-08-10 8-K 8-K 2.02,9.01 0001193125-21-241222 001-38529 211158469 34 257508 1 1
2021-07-20 4 FORM 4 SUBMISSION 0001209191-21-047477 5581
2021-07-20 3 FORM 3 SUBMISSION 0001209191-21-047472 7101
2021-07-09 8-K 8-K 5.02 0001193125-21-211337 001-38529 211081708 34 161448 1 1
2021-06-17 4/A FORM 4/A SUBMISSION 0001209191-21-041449 5953
2021-06-17 4/A FORM 4/A SUBMISSION 0001209191-21-041447 5977
2021-06-17 4/A FORM 4/A SUBMISSION 0001209191-21-041444 5983
2021-06-17 4/A FORM 4/A SUBMISSION 0001209191-21-041443 5989
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040269 5524
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040267 5494
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040265 5530
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040264 5518
2021-06-10 8-K 8-K 5.07 0001193125-21-187840 001-38529 211008587 34 155204 1 1
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038482 5122
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038481 5146
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038480 5135
2021-05-28 8-K 8-K 8.01,9.01 0001193125-21-176231 001-38529 21976126 34 170413 1 1
2021-05-07 S-8 S-8 0001193125-21-155019 333-255919 21903426 33 67312
2021-05-07 10-Q 10-Q 0001564590-21-025318 001-38529 21900330 34 7460714 1 1
2021-05-07 8-K 8-K 2.02,9.01 0001193125-21-154092 001-38529 21900273 34 228866 1 1
2021-04-23 DEFA14A DEFA14A 0001193125-21-127788 001-38529 21846667 34 156417
2021-04-23 DEF 14A DEF 14A 0001193125-21-127783 001-38529 21846661 34 492384
2021-04-19 SEC STAFF LETTER filename1.pdf 9999999997-21-001357 274569
2021-03-29 4 FORM 4 SUBMISSION 0001209191-21-023388 7665
2021-03-23 8-K 8-K 1.01,8.01,9.01 0001193125-21-091371 001-38529 21765666 34 432050 1 1
2021-03-23 424B5 424B5 0001193125-21-091358 333-237171 21765650 33 520420
2021-03-22 424B5 424B5 0001193125-21-089577 333-237171 21761602 33 524666
2021-03-22 SEC STAFF LETTER filename1.pdf 9999999997-21-000552 277077
2021-03-17 10-K 10-K 0001564590-21-013876 001-38529 21750838 34 10301398 1 1
2021-03-17 8-K 8-K 1.01 0001193125-21-083540 001-38529 21748485 34 152996 1 1
2021-03-04 8-K FORM 8-K 2.02,9.01 0001193125-21-068558 001-38529 21712657 34 215726 1 1
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-017004 5577
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016997 5588
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016984 5590
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016978 5591
2021-03-03 4 FORM 4 SUBMISSION 0001209191-21-016972 5598
2021-02-17 8-K FORM 8-K 8.01,9.01 0001193125-21-045850 001-38529 21642723 34 173415 1 1
2021-02-17 SC 13G/A SC 13G/A 0001193125-21-045466 005-90530 21642226 34 64532
2021-02-16 SC 13G/A AMENDMENT TO FORM SC13G 0001387131-21-002489 005-90530 21638008 34 141123
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-044763 005-90530 21637471 34 65256
2021-01-25 SC 13G/A SC 13G/A 0001193125-21-016443 005-90530 21550726 34 48536
2021-01-06 8-K FORM 8-K 7.01,9.01 0001193125-21-002410 001-38529 21508927 34 11715397 1 1
2020-12-23 8-K FORM 8-K 8.01 0001193125-20-325991 001-38529 201412366 34 147243 1 1
2020-11-10 8-K 8-K 7.01,9.01 0001193125-20-289663 001-38529 201299663 34 23890549 1 1
2020-11-09 10-Q 10-Q 0001564590-20-052242 001-38529 201296291 34 7826003 1 1
2020-11-09 8-K 8-K 2.02,9.01 0001193125-20-288501 001-38529 201296123 34 207150 1 1
2020-09-08 8-K 8-K 7.01,9.01 0001193125-20-240495 001-38529 201162929 34 15126178 1 1
2020-08-26 4 FORM 4 SUBMISSION 0001209191-20-048401 6847
2020-08-21 4 FORM 4 SUBMISSION 0001209191-20-047865 7182
2020-08-19 4 FORM 4 SUBMISSION 0001209191-20-047409 7181
2020-08-18 4 FORM 4 SUBMISSION 0001209191-20-047100 7179
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046963 6828
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046962 5137
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046961 5120
2020-08-17 4 FORM 4 SUBMISSION 0001209191-20-046880 9400
2020-08-11 8-K FORM 8-K 1.01 0001193125-20-215626 001-38529 201091058 34 153321 1 1
2020-08-05 10-Q 10-Q 0001564590-20-036455 001-38529 201075712 34 6670358 1 1
2020-08-05 8-K FORM 8-K 2.02,9.01 0001193125-20-209871 001-38529 201075636 34 68191
2020-08-03 4 FORM 4 SUBMISSION 0001209191-20-044549 5592
2020-08-03 4 FORM 4 SUBMISSION 0001209191-20-044548 5523
2020-08-03 3 FORM 3 SUBMISSION 0001209191-20-044547 8417
2020-07-23 8-K FORM 8-K 5.02,7.01,9.01 0001193125-20-197468 001-38529 201042752 34 66849
2020-07-14 8-K FORM 8-K 2.02,8.01,9.01 0001193125-20-192263 001-38529 201026302 34 43046
2020-06-29 8-K 8-K 8.01,9.01 0001193125-20-182369 001-38529 20997625 34 41603
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036345 5527
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036321 5525
2020-06-12 4 FORM 4 SUBMISSION 0001209191-20-036318 5495
2020-06-11 4 FORM 4 SUBMISSION 0001209191-20-035997 5509
2020-06-11 3 FORM 3 SUBMISSION 0001209191-20-035994 7621
2020-06-11 8-K 8-K 5.07 0001193125-20-166653 001-38529 20957349 34 24119
2020-06-10 8-K FORM 8-K 5.02,7.01,9.01 0001193125-20-165142 001-38529 20953501 34 39910
2020-05-07 10-Q 10-Q 0001564590-20-022364 001-38529 20854568 34 6121655 1
2020-05-07 8-K FORM 8-K 2.02,9.01 0001193125-20-135570 001-38529 20854543 34 58785
2020-04-24 DEFA14A DEFA14A 0001193125-20-118149 001-38529 20812487 34 87487
2020-04-24 DEF 14A DEF 14A 0001193125-20-118119 001-38529 20812481 34 468908
2020-04-17 8-K 8-K 7.01,8.01,9.01 0001193125-20-109995 001-38529 20797769 34 21360077
2020-03-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-03-25 16:30:00 9999999995-20-000620 333-237171 20743866 33 1731
2020-03-23 CORRESP filename1.htm 0001193125-20-082429 5853
2020-03-23 UPLOAD filename1.pdf 0000000000-20-002517 39901
2020-03-13 S-8 FORM S-8 0001193125-20-073011 333-237174 20713522 33 66395
2020-03-13 S-3 FORM S-3 0001193125-20-072993 333-237171 20713459 33 1010745
2020-03-13 10-K 10-K 0001564590-20-010832 001-38529 20712934 34 10294242 1
2020-03-13 8-K FORM 8-K 1.01,2.02,2.03,7.01,9.01 0001193125-20-072873 001-38529 20712652 34 104685
2020-03-03 4 FORM 4 SUBMISSION 0001209191-20-015606 5598
2020-03-03 3 FORM 3 SUBMISSION 0001209191-20-015596 9790
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014686 5581
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014683 5592
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014682 5594
2020-03-02 4 FORM 4 SUBMISSION 0001209191-20-014679 5595
2020-03-02 8-K FORM 8-K 7.01,9.01 0001193125-20-057796 001-38529 20674176 34 12360193
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038428 005-90530 20621072 34 65814
2020-02-03 SC 13G/A SC 13G/A 0001104659-20-009399 005-90530 20566485 34 87508
2020-01-30 SC 13G/A SC 13G/A 0001104659-20-008705 005-90530 20561554 34 47066
2020-01-16 8-K FORM 8-K 5.02 0001193125-20-008968 001-38529 20531047 34 24184
2019-11-20 8-K FORM 8-K 3.01 0001193125-19-296660 001-38529 191234978 34 18657
2019-11-06 10-Q 10-Q 0001564590-19-041122 001-38529 191197134 34 6012996 1
2019-11-06 8-K FORM 8-K 2.02,9.01 0001193125-19-285916 001-38529 191196540 34 65712
2019-10-24 8-K FORM 8-K 5.02 0001193125-19-273585 001-38529 191166546 34 25435
2019-10-21 4 FORM 4 SUBMISSION 0001209191-19-053716 5586
2019-10-21 3 FORM 3 SUBMISSION 0001209191-19-053713 7090
2019-10-18 8-K FORM 8-K 7.01,9.01 0001193125-19-269686 001-38529 191156609 34 20269769
2019-10-10 4 FORM 4 SUBMISSION 0001209191-19-052936 11720
2019-10-10 8-K FORM 8-K 5.02,9.01 0001193125-19-265842 001-38529 191146326 34 45220
2019-10-04 8-K 8-K 5.02 0001193125-19-262750 001-38529 191138792 34 17070
2019-09-09 4 FORM 4 SUBMISSION 0001209191-19-048940 13542
2019-08-29 4 FORM 4 SUBMISSION 0001209191-19-047734 7319
2019-08-09 4 FORM 4 SUBMISSION 0001209191-19-045382 9393
2019-08-07 10-Q 10-Q 0001564590-19-030121 001-38529 191005904 34 6234852 1
2019-08-07 8-K FORM 8-K 2.02,9.01 0001193125-19-215354 001-38529 191005753 34 69235
2019-08-06 4 FORM 4 SUBMISSION 0001209191-19-044881 9394
2019-08-01 4 FORM 4 SUBMISSION 0001209191-19-044073 9393

Latest XBRL company facts

One latest value per concept from companyfacts (314 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 17.18M 2026-11-05 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
dei EntityPublicFloat Entity Public Float USD 27.30M 2025-06-30 2025 FY 10-K 2026-03-11 0001660334-26-000008
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 692,881 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163961
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 905,731 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163961
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 30.22 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163961
ffd NetFeeAmt NetFeeAmt USD 644.34 2026-05-11 S-8 2026-05-12 0001193125-26-219912
ffd TtlFeeAmt TtlFeeAmt USD 644.34 2026-05-11 S-8 2026-05-12 0001193125-26-219912
ffd TtlOfferingAmt TtlOfferingAmt USD 4.67M 2026-05-11 S-8 2026-05-12 0001193125-26-219912
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-11 S-8 2026-05-12 0001193125-26-219912
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 11.24M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-022659
us-gaap AccretionExpense Accretion Expense USD 375,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001660334-25-000006
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.04M 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 918,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.05M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 121.86M 2018-06-30 2018 Q2 10-Q 2018-08-07 0001193125-18-240959
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 354.18M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.91M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 9,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AdvertisingExpense Advertising Expense USD 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap Assets Assets USD 39.86M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AssetsCurrent Assets, Current USD 36.40M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 29,000 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 54.63M 2021-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax USD 7,000 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028111
us-gaap AvailableForSaleEquitySecuritiesAmortizedCostBasis Available-for-sale Equity Securities, Amortized Cost Basis USD 58.67M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028111
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap AvailableForSaleSecuritiesEquitySecurities Available-for-sale Securities, Equity Securities USD 58.66M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028111
us-gaap AvailableForSaleSecuritiesEquitySecuritiesCurrent Available-for-sale Securities, Equity Securities, Current USD 79.54M 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006800
us-gaap AvailableForSaleSecuritiesEquitySecuritiesNoncurrent Available-for-sale Securities, Equity Securities, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-17 0001564590-21-013876
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 14.39M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 9.58M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030121
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 10.00M 2025-03-31 2025 Q1 10-Q 2025-05-13 0000950170-25-070452
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 14.66M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -15.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 95.6 2024-05-14 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 50,000 2024-05-14 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 17.19M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 17.18M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -67.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-022659
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ContractWithCustomerRefundLiabilityCurrent Contract with Customer, Refund Liability, Current USD 1.70M 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-120982
us-gaap CostOfRevenue Cost of Revenue USD 700,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-13 0000950170-25-070452
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037172
us-gaap DebtCurrent Debt, Current USD 40.67M 2021-03-31 2021 Q1 10-Q 2021-05-07 0001564590-21-025318
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 3.80M 2022-07-11 2023 FY 10-K 2024-02-29 0000950170-24-022659
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2023-07-26 2025 Q2 10-Q 2025-08-12 0000950170-25-107358
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 213,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -2.40M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-02 0000950170-22-002685
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 389,000 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredRentCredit Deferred Rent Credit USD 2,000 2019-01-01 2020 FY 10-K 2021-03-17 0001564590-21-013876
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 481,000 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107358
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 74.13M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.40M 2020-12-31 2020 FY 10-K 2021-03-17 0001564590-21-013876
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 389,000 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 58.66M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.56M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 3.25M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.20M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 73.74M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037172
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 8,000 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 1.24M 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap Depreciation Depreciation USD 42,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap DerivativeLiabilities Derivative Liability USD 600,000 2026-09-17 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 556,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 38,000 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap EarlyRepaymentOfSeniorDebt Early Repayment of Senior Debt USD 35.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.31 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008242
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.65 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.159 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 410,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.023 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.96M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 300,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041122
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 5.50M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001660334-26-000014
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 2.40M 2023-07-26 2025 Q1 10-Q 2025-05-13 0000950170-25-070452
us-gaap FairValueDisclosureOffbalanceSheetRisksAmountAsset Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset USD 0 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107358
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 64,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 1.34M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 564,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 773,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 599,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 61,000 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 230,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 401,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 173,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 134,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 346,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 330,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.076 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -246,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -1.53M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.26M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039375
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -459,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037172
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -3.76M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 117,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1.93M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037172
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 343,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 173,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037172
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -998,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 5.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.39M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-17 0001564590-21-013876
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 323,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 481,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107358
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 6,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022364
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD -32,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030121
us-gaap IncreaseDecreaseInInsuranceSettlementsReceivable Increase (Decrease) in Insurance Settlements Receivable USD 2.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 568,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -253,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 10,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052242
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 927,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -19,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041122
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061543
us-gaap InsuranceSettlementsReceivableCurrent Insurance Settlements Receivable, Current USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap InterestBearingDepositsInBanks Interest-bearing Deposits in Banks and Other Financial Institutions USD 300,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001660334-26-000014
us-gaap InterestExpense Interest Expense USD 4.69M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0000950170-24-096669
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 609,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 2,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006800
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 64,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 1.11M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap InventoryNet Inventory, Net USD 2.80M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 924,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 772,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 357,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 369,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 612,000 2020-12-31 2020 FY 10-K 2021-03-17 0001564590-21-013876
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 58,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041122
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 58,000 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022364
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 139,000 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 246,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 360,000 2020-12-31 2020 FY 10-K 2021-03-17 0001564590-21-013876
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 123,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 39,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap Liabilities Liabilities USD 45.84M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 39.86M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LiabilitiesCurrent Liabilities, Current USD 21.93M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2025-12-31 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LineOfCreditFacilityCommitmentFeeAmount Line of Credit Facility, Commitment Fee Amount USD 500.00M 2024-06-26 2025 Q1 10-Q 2025-05-13 0000950170-25-070452
us-gaap LitigationReserve Estimated Litigation Liability USD 0 2018-06-30 2018 Q2 10-Q 2018-08-07 0001193125-18-240959
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 4.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 800,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-120982
us-gaap LongTermDebt Long-term Debt USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 15.28M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001660334-25-000006
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 4.38M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022364
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 8.75M 2024-12-31 2024 FY 10-K 2025-03-11 0000950170-25-037172
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 8.75M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001660334-25-000006
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 15.00M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001660334-25-000006
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 3.89M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001660334-25-000006
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 11.64M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 400,000 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-120982
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number claim 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-022659
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 11.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -27.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -35.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -22.84M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001660334-26-000025
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -22.84M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001660334-26-000025
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 733,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107358
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -263,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingExpenses Operating Expenses USD 52.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -34.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingLeaseCost Operating Lease, Cost USD 256,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 292,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-120982
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 330,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 330,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingLeasePayments Operating Lease, Payments USD 68,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030121
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 304,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 236,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 333,000 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 136,000 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006800
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree Operating Leases, Future Minimum Payments, Due in Rolling Year Three USD 58,000 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo Operating Leases, Future Minimum Payments, Due in Rolling Year Two USD 139,000 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 58,000 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006800
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 139,000 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006800
us-gaap OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths Operating Leases, Future Minimum Payments, Next Rolling Twelve Months USD 136,000 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 94,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-07 0001564590-21-025318
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.063 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 19,000 2019-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 638,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-022659
us-gaap OtherExpenses Other Expenses USD 1,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-17 0001564590-21-013876
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 33,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 75,000 2020-06-30 2020 Q2 10-Q 2020-08-05 0001564590-20-036455
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -11,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 2.20M 2023-02-01 2023-02-28 2023 Q3 10-Q 2023-11-09 0000950170-23-061543
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 156,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PaymentsOfDebtRestructuringCosts Payments of Debt Restructuring Costs USD 110,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-022659
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 700,000 2023-12-31 2024 Q2 10-Q 2024-08-14 0000950170-24-096669
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 86.25M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 39.60M 2024-11-01 2024-11-30 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 35.00M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052242
us-gaap ProceedsFromLegalSettlements Proceeds from Legal Settlements USD 800,000 2024-01-01 2024-12-31 2025 Q1 10-Q 2025-05-13 0000950170-25-070452
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 12.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-022659
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ProductionRelatedImpairmentsOrCharges Production Related Impairments or Charges USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -9.54M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107358
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.26M 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 167,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 259,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061543
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 17.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap RestrictedCash Restricted Cash USD 262,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -360.15M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 16.14M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107358
us-gaap Revenues Revenues USD 17.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 306,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030121
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 49.10M 2025-11-01 2025-11-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 30.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap SeveranceCosts1 Severance Costs USD 300,000 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-120982
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 125,000 2020-08-01 2020-08-31 2024 Q3 10-Q 2024-11-05 0000950170-24-120982
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.774 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.837 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-07 0001193125-18-240959
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.706 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-07 0001193125-18-240959
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.025 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-07 0001564590-19-030121
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.03 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-07 0001193125-18-240959
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.026 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-07 0001193125-18-240959
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 4,071 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 178,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 27,677 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 128,780 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.98 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001660334-26-000014
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 3,479 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.91M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.37 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 403 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 537,263 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 26.74 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 36.16 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 14.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 8.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 7.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap SharePrice Share Price USD/shares 6.52 2018-03-28 2018 Q2 10-Q 2018-08-07 0001193125-18-240959
us-gaap SharesIssued Shares, Issued shares 2.58M 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-120982
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 8.9 2024-11-30 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap ShortTermBorrowings Short-term Debt USD 0 2022-12-31 2022 FY 10-K 2023-03-06 0000950170-23-006118
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058208
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -5.97M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2025-07-24 2026 Q1 10-Q 2026-05-12 0001660334-26-000014
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 4,000 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058208
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 6.50M 2025-11-01 2025-11-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 51,049 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052242
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 4,250 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 36.50M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 36.50M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-13 0001564590-20-010832
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 49.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 155,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 15.51M 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006800
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 10,514 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap TreasuryStockShares Treasury Stock, Shares shares 105,144 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019169
us-gaap TreasuryStockValue Treasury Stock, Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 46,000 2025-03-31 2025 Q1 10-Q 2025-05-13 0000950170-25-070452
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.50M 2019-12-31 2021 FY 10-K 2022-03-02 0000950170-22-002685
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-11 0001660334-26-000008
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 21.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 27.52M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008242
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 21.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001660334-26-000030

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →